GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Deep Medicine Acquisition Corp (NAS:DMAQ) » Definitions » Net Change in Cash

Deep Medicine Acquisition (Deep Medicine Acquisition) Net Change in Cash : $-0.91 Mil (TTM As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Deep Medicine Acquisition Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Deep Medicine Acquisition's Net Change in Cash for the three months ended in Sep. 2023 was $-0.19 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.91 Mil.

Deep Medicine Acquisition Net Change in Cash Historical Data

The historical data trend for Deep Medicine Acquisition's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deep Medicine Acquisition Net Change in Cash Chart

Deep Medicine Acquisition Annual Data
Trend Mar21 Mar22 Mar23
Net Change in Cash
- 0.38 -0.28

Deep Medicine Acquisition Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.19 -0.31 -0.37 -0.05 -0.19

Deep Medicine Acquisition Net Change in Cash Calculation

Deep Medicine Acquisition's Net Change in Cash for the fiscal year that ended in Mar. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-1.036+120.425+-119.67+0
=-0.28

Deep Medicine Acquisition's Net Change in Cash for the quarter that ended in Sep. 2023

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.269+2.914+-2.83+0
=-0.19

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Deep Medicine Acquisition Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Deep Medicine Acquisition's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Deep Medicine Acquisition (Deep Medicine Acquisition) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Deep Medicine Acquisition Corp (NAS:DMAQ) » Definitions » Net Change in Cash
Comparable Companies
CLRC QOMO VSAC KACL DHAC ENCP PCCT MTRY PLTN ACAX PBAJ SVMB SCRM CVII AAC GHIX ALCC AACT DWAC SAGA
Traded in Other Exchanges
N/A
Address
595 Madison Avenue, 12th Floor, New York, NY, USA, 10017
Website
Deep Medicine Acquisition Corp is a blank check company.
Executives
John Chiang director 3538 TORRANCE BLVD., UNIT 177, TORRANCE CA 90503
Bryant Fong director 2170 VALLEJO STREET #101, SAN FRANCISCO CA 94123
Humphrey P Polanen director, officer: Chief Executive Officer C/O HERITAGE COMMERCE CORP, 150 ALMADEN BLVD, SAN JOSE CA 95113
Weixuan Luo officer: Chief Financial Officer 40 WALL STREET, 29TH FLOOR, NEW YORK NY 10005
Marc Hamer director 7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Bright Vision Sponsor Llc 10 percent owner 7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Ronald M. Razmi director 7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Hongliang Ren director 7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Wanlei Miao director 595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017
Tina Spires director 595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017

Deep Medicine Acquisition (Deep Medicine Acquisition) Headlines

From GuruFocus

Deep Medicine Acquisition Corp. Announces Appointment of a New Director

By GlobeNewswire GlobeNewswire • 10-24-2022

Deep Medicine Acquisition Corp. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with TruGolf, Inc.

By GlobeNewswire • 08-03-2023

Deep Medicine Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination

By Value_Insider Value_Insider • 10-20-2022

Deep Medicine Acquisition Corp. Completes Upsized $126,500,000 Initial Public Offering, Including Full Exercise of Over-Allotment Option

By Marketwired Marketwired • 10-29-2021

Deep Medicine Acquisition Corp. Announces Appointment of a New Director

By Value_Insider Value_Insider • 10-24-2022

Chijet Motor Company, Inc. has entered into a business combination agreement with Deep Medicine Acquisition Corp. to become a public company to advance its electric vehicle business and sales of gasoline vehicles in China and Southeast Asia

By PurpleRose PurpleRose • 07-13-2022

Thinking about buying stock in Canoo, Recursion Pharmaceuticals, Knightscope, Deep Medicine Acquisition, or Digital World Acquisition?

By PRNewswire • 07-19-2023

Deep Medicine Acquisition Corp. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with TruGolf, Inc.

By Marketwired • 08-03-2023

Deep Medicine Acquisition Corp. Announces Listing Transfer to the Nasdaq Capital Market

By sperokesalga sperokesalga • 02-16-2023

Deep Medicine Acquisition Corp. Announces Upcoming Automatic Unit Separation

By GuruFocusNews GuruFocusNews • 11-30-2021